Global Blood Group Typing Market Size Study & Forecast, by Product (Consumables, Instruments, Services), Test Type (ABO, Antigen, Antibody, HLA), Technique (Assay-based, PCR, Microarray, Massively Parallel Sequencing), End User (Hospital, Blood Banks) and

The Global Blood Group Typing Market, valued at approximately USD 2.13 billion in 2024, is projected to expand at a promising CAGR of 8.70% between 2025 and 2035, ultimately reaching USD 5.33 billion by the end of the forecast period. Blood group typing, a cornerstone diagnostic procedure in modern healthcare, is pivotal for safe blood transfusions, organ transplants, prenatal testing, and emergency medicine. The process involves the precise identification of blood types through advanced serological and molecular techniques, ensuring compatibility and reducing risks of transfusion reactions. Growing incidences of trauma cases, chronic diseases requiring repeated transfusions, and the increasing prevalence of prenatal testing have amplified the demand for efficient, high-throughput typing methods. Furthermore, rapid technological advancements—ranging from microarray-based platforms to massively parallel sequencing—are streamlining workflows while enhancing accuracy, paving the way for faster diagnostics in both clinical and research settings.

A significant catalyst for market expansion lies in the rising global demand for blood and blood products, propelled by aging populations and the growing complexity of surgical interventions. According to global healthcare statistics, millions of units of blood are transfused annually, and emerging economies are witnessing substantial growth in organized blood banking services. The development of portable, point-of-care blood typing devices is expected to revolutionize field diagnostics, particularly in military, disaster relief, and rural healthcare environments. At the same time, integration of automation and AI-driven interpretation tools is reducing human error, thereby improving reliability and patient safety. Despite these advancements, high operational costs and the need for skilled technicians to interpret complex results remain as challenges. However, ongoing R&D investments in cost-effective consumables and reagent stability are anticipated to mitigate these constraints in the coming decade.

From a geographical perspective, North America currently leads the blood group typing market, supported by a mature healthcare infrastructure, strong presence of diagnostic technology innovators, and a well-regulated blood donation ecosystem. The United States, with its vast network of hospitals, blood banks, and research laboratories, remains a key contributor. Europe follows closely, driven by nationalized healthcare systems, stringent quality regulations for transfusion safety, and continuous technological adoption in countries such as Germany, the UK, and France. Asia Pacific is projected to be the fastest-growing region during the forecast period, fueled by rapidly improving healthcare access, rising surgical volumes, and government-backed initiatives to strengthen blood transfusion services in China, India, and Southeast Asia. Meanwhile, Latin America and the Middle East & Africa are emerging as promising frontiers, as local healthcare systems invest in infrastructure upgrades and forge collaborations with global diagnostic providers.

Major market players included in this report are:
• Grifols, S.A.
• Bio-Rad Laboratories, Inc.
• Immucor, Inc.
• Quotient Limited
• Ortho Clinical Diagnostics
• Beckman Coulter, Inc. (Danaher Corporation)
• Thermo Fisher Scientific Inc.
• Siemens Healthineers AG
• Abbott Laboratories
• Becton, Dickinson and Company
• Agena Bioscience, Inc.
• BAG Healthcare GmbH
• Novacyt Group
• AXO Science
• Tulip Diagnostics (P) Ltd.

Global Blood Group Typing Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period – 2025-2035
• Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players.

The detailed segments and sub-segments of the market are explained below:

By Product:
• Consumables
• Instruments
• Services

By Test Type:
• ABO
• Antigen
• Antibody
• HLA

By Technique:
• Assay-based
• PCR
• Microarray
• Massively Parallel Sequencing

By End User:
• Hospital
• Blood Banks

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico

Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions. Show more